Akebia Therapeutics, Inc.
Ownership
Ownership Structure
Who owns Akebia Therapeutics, Inc. (AKBA)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 97.7% of the shares are freely tradable; institutional investors hold 42.1%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 6.75 | 18,693,296 | -3.2 | 03/31/2026 |
| State Street Corp | 4.19 | 11,614,006 | -15.1 | 03/31/2026 |
| Vanguard Capital Management, LLC | 4.03 | 11,166,710 | +0.0 | 03/31/2026 |
| Geode Capital Management, LLC | 2.33 | 6,452,252 | +2.8 | 03/31/2026 |
| The Goldman Sachs Group Inc | 1.30 | 3,602,827 | -23.4 | 03/31/2026 |
| Millennium Management LLC | 1.15 | 3,196,605 | +34.0 | 06/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard MStar Total Stk Mkt Idx Invest | 2.86 | 7,912,283 | +0.0 | 07/31/2026 |
| iShares Russell 2000 ETF | 2.41 | 6,690,646 | -0.6 | 08/31/2026 |
| Foord Global Equity (Lux) A | 1.37 | 3,788,401 | +0.0 | 06/30/2026 |
| Vanguard Institutional Extnd Mkt Idx Tr | 1.14 | 3,166,072 | +0.0 | 07/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Butler John P. | CEO and President | 3,718,564 | 3,329,974 $ | Aug 6, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 6, 2026 | Butler John P. | CEO and President | Other | 350,000 | 0.63 | 220,500 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.